Shreyas Joshi MD MPH (@ssjoshimd) 's Twitter Profile
Shreyas Joshi MD MPH

@ssjoshimd

Assistant Professor in Urologic Oncology, Emory University, Winship Cancer Institute - opinions/views my own

ID: 756301180951793664

calendar_today22-07-2016 01:33:47

437 Tweet

625 Followers

412 Following

Ruchika Talwar (@ruchikatalwarmd) 's Twitter Profile Photo

High-risk #NMIBC remains a complex, ever-evolving space in the era of BCG shortages and innovation with new intravesical, IV, and oral therapies 💉💊 Amy Luckenbaugh and Shreyas Joshi MD MPH share their expertise, simplifying the clinical challenges urologists often face #SESAUA24

High-risk #NMIBC remains a complex, ever-evolving space in the era of BCG shortages and innovation with new intravesical, IV, and oral therapies 💉💊

<a href="/AmyLuckenbaugh/">Amy Luckenbaugh</a> and <a href="/ssjoshimd/">Shreyas Joshi MD MPH</a> share their expertise, simplifying the clinical challenges urologists often face #SESAUA24
Alexander Kutikov MD (@uretericbud) 's Twitter Profile Photo

What a night at the Fox Chase - Temple Urologic Institute reception and dinner! Phenomenal to see all the grads (alumni annual group pic always an adventure!) and friends of Fox Chase Cancer Center Department of Urology / Temple Urology from around the world! #aua24 #AUA2024

What a night at the Fox Chase - Temple Urologic Institute reception and dinner! Phenomenal to see all the grads (alumni annual group pic always an adventure!) and friends of <a href="/FCUroOnc/">Fox Chase Cancer Center Department of Urology</a> / <a href="/TempleUrology/">Temple Urology</a> from around the world!  #aua24 #AUA2024
Vikram M. Narayan, MD (@vikramnarayan) 's Twitter Profile Photo

Happy to have been able to share these important data on behalf of Society of Urologic Oncology CTC to help patients/physicians better counsel patients when evaluating treatment options for BCG unresponsive NMIBC. Emory Urologic Oncology MD Anderson Cancer Center Emory Urology 1/

Laura Bukavina (@laurabukavinamd) 's Twitter Profile Photo

2x as long.. 15K more expensive. No ROBF benefit, No complication benefit.. data is pretty clear.. and yes this was intracorporeal > Safe to do both but 🤖 clearly not superior . Robot is a tool not a necessity. read here⤵️European Urology europeanurology.com/article/S0302-…

2x as long.. 15K more expensive. No ROBF benefit, No complication benefit.. data is pretty clear.. and yes this was intracorporeal &gt; Safe to do both but 🤖 clearly not superior . Robot is a tool not a necessity. read here⤵️<a href="/EUplatinum/">European Urology</a> europeanurology.com/article/S0302-…
Roger Li (@urogerlimd) 's Twitter Profile Photo

Final results of #CORE001 trial out now Nature Medicine (1/14) 35 pts with BCG-UR CIS treated w/ Creto + pembro 👉12mo CR (per RBB) = 57.1% (ITT) 👉24mo CR = 54% *(Auth Corr) 👉No patient progressed to MIBC 👉No synergistic toxicity Gary Steinberg nature.com/articles/s4159…

Final results of #CORE001 trial out now <a href="/NatureMedicine/">Nature Medicine</a> (1/14)

35 pts with BCG-UR CIS treated w/ Creto + pembro

👉12mo CR (per RBB) = 57.1% (ITT)
👉24mo CR = 54% *(Auth Corr)
👉No patient progressed to MIBC
👉No synergistic toxicity

<a href="/garysteinbergmd/">Gary Steinberg</a>

nature.com/articles/s4159…
Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

🚨 Amer. Urol. Assn. Data Research Program🚨 What: Access & 💵💰($2K) to investigate the The AUA Quality (AQUA) Registry data & the AUA Annual Census Who: 🙌ANY AUA member including trainees & students Why: Promote research 🔬on urology practice & workforce When:👇Key dates

🚨 <a href="/AmerUrological/">Amer. Urol. Assn.</a> Data Research Program🚨

What: Access &amp; 💵💰($2K) to investigate the The AUA Quality (AQUA) Registry data &amp; the AUA Annual Census

Who: 🙌ANY AUA member including trainees &amp; students

Why: Promote research 🔬on urology practice &amp; workforce

When:👇Key dates
Emory Urology (@emory_urology) 's Twitter Profile Photo

This upcoming Saturday, our beloved chiefs will be graduating from our program. Their dedication to our patients, skill, and compassion has inspired us all. Stay tuned as we celebrate each one of these amazing individuals on our feed! 🎉 #EmoryUrology #ChiefGraduation #UroSoMe

This upcoming Saturday, our beloved chiefs will be graduating from our program. Their dedication to our patients, skill, and compassion has inspired us all. Stay tuned as we celebrate each one of these amazing individuals on our feed! 🎉 #EmoryUrology #ChiefGraduation #UroSoMe
Emory Urology (@emory_urology) 's Twitter Profile Photo

Up first, Ben Croll aka Benjamin Croll. A future urologic oncologist in the making. Ben will be joining Fox Chase Cancer Center Department of Urology for their 2-year SUO fellowship. He will then be taking his talents to San Antonio on Active Duty as the Urologic Oncologist for the US Air Force 🇺🇸

Up first, Ben Croll aka <a href="/UroCroll/">Benjamin Croll</a>. A future urologic oncologist in the making. Ben will be joining <a href="/FCUroOnc/">Fox Chase Cancer Center Department of Urology</a> for their 2-year SUO fellowship. He will then be taking his talents to San Antonio on Active Duty as the Urologic Oncologist for the US Air Force 🇺🇸
Targeted Oncology (@targetedonc) 's Twitter Profile Photo

A long-term analysis of the phase 3 Study CS-003 trial continues to support treatment with nadofaragene firadenovec for patients with high-risk, BCG-unresponsive #NMIBC. Learn more in this interview with Vikram M. Narayan, MD of Winship Cancer Institute of Emory University & Emory Urology. targetedonc.com/view/long-term…

A long-term analysis of the phase 3 Study CS-003 trial continues to support treatment with nadofaragene firadenovec for patients with high-risk, BCG-unresponsive #NMIBC. Learn more in this interview with <a href="/VikramNarayan/">Vikram M. Narayan, MD</a> of <a href="/WinshipAtEmory/">Winship Cancer Institute of Emory University</a> &amp; <a href="/emory_urology/">Emory Urology</a>.

targetedonc.com/view/long-term…
Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Winship urologist Shreyas Joshi, MD, MPH, provides an update on current and emerging treatment approaches for patients with non-muscle invasive bladder cancer and muscle invasive bladder cancer. #DDHO2024

Winship urologist Shreyas Joshi, MD, MPH, provides an update on current and emerging treatment approaches for patients with non-muscle invasive bladder cancer and muscle invasive bladder cancer. #DDHO2024